Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

Regeneron Pharmaceuticals (REGN)

Regeneron Pharmaceuticals (REGN)
501.00 x 1 565.00 x 1
Post-market by (Cboe BZX)
554.18 +7.79 (+1.43%) 04/11/25 [NASDAQ]
501.00 x 1 565.00 x 1
Post-market 556.81 +2.63 (+0.47%) 18:32 ET
Quote Overview for Fri, Apr 11th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
533.26
Day High
555.53
Open 548.63
Previous Close 546.39 546.39
Volume 1,171,100 1,171,100
Avg Vol 1,115,745 1,115,745
Stochastic %K 23.64% 23.64%
Weighted Alpha -47.06 -47.06
5-Day Change -19.27 (-3.36%) -19.27 (-3.36%)
52-Week Range 525.99 - 1,211.20 525.99 - 1,211.20
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 60,585,720
  • Shares Outstanding, K 109,325
  • Annual Sales, $ 14,202 M
  • Annual Income, $ 4,413 M
  • EBIT $ 3,991 M
  • EBITDA $ 4,474 M
  • 60-Month Beta 0.44
  • Price/Sales 4.21
  • Price/Cash Flow 11.96
  • Price/Book 2.04

Options Overview Details

View History
  • Implied Volatility 54.67% ( -2.16%)
  • Historical Volatility 40.19%
  • IV Percentile 98%
  • IV Rank 87.45%
  • IV High 60.01% on 04/08/25
  • IV Low 17.43% on 06/12/24
  • Put/Call Vol Ratio 5.77
  • Today's Volume 4,104
  • Volume Avg (30-Day) 1,817
  • Put/Call OI Ratio 0.83
  • Today's Open Interest 41,303
  • Open Int (30-Day) 38,612

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 25 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 6.84
  • Number of Estimates 5
  • High Estimate 7.66
  • Low Estimate 5.73
  • Prior Year 7.97
  • Growth Rate Est. (year over year) -14.18%

Price Performance

See More
Period Period Low Period High Performance
1-Month
525.99 +5.36%
on 04/09/25
Period Open: 718.16
712.46 -22.22%
on 03/12/25
-163.98 (-22.83%)
since 03/11/25
3-Month
525.99 +5.36%
on 04/09/25
Period Open: 696.88
748.29 -25.94%
on 03/10/25
-142.70 (-20.48%)
since 01/10/25
52-Week
525.99 +5.36%
on 04/09/25
Period Open: 920.32
1,211.20 -54.25%
on 08/27/24
-366.14 (-39.78%)
since 04/11/24

Most Recent Stories

More News
Stocks Spike as Trump Announces 90-Day Tariff Pause

The S&P 500 Index ($SPX ) (SPY ) today is up +5.99%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +3.96%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +7.05%. June E-mini S&P futures (ESM25...

ALK : 45.76 (+2.81%)
GOOGL : 157.14 (+2.83%)
MPC : 123.43 (+1.56%)
AAPL : 198.15 (+4.06%)
JNJ : 151.73 (+2.04%)
AMGN : 285.98 (+1.62%)
PFE : 21.91 (+1.48%)
OXY : 37.67 (+3.29%)
TSLA : 252.31 (-0.04%)
FANG : 129.01 (+4.75%)
AMD : 93.40 (+5.30%)
SPY : 533.94 (+1.78%)
Stocks Supported by Strength in Megacap Technology and Airline Stocks

The S&P 500 Index ($SPX ) (SPY ) today is up +0.64%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.29%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.49%. June E-mini S&P futures (ESM25...

ALK : 45.76 (+2.81%)
GOOGL : 157.14 (+2.83%)
MPC : 123.43 (+1.56%)
AAPL : 198.15 (+4.06%)
ADI : 179.16 (+0.45%)
JNJ : 151.73 (+2.04%)
AMGN : 285.98 (+1.62%)
PFE : 21.91 (+1.48%)
OXY : 37.67 (+3.29%)
TSLA : 252.31 (-0.04%)
FANG : 129.01 (+4.75%)
AMD : 93.40 (+5.30%)
4 Beaten-Down Stocks That Could Skyrocket by 50% to 543%, According to Wall Street

As biotech investors know, companies in the industry can sometimes earn significant returns in relatively short periods, like a year, thanks to excellent clinical or regulatory progress. And based on Wall...

CRSP : 39.30 (+14.71%)
IOVA : 3.30 (+7.84%)
SRPT : 51.03 (+1.43%)
REGN : 554.18 (+1.43%)
Immuno-Oncology Stocks Q4 Highlights: Incyte (NASDAQ:INCY)

Immuno-Oncology Stocks Q4 Highlights: Incyte (NASDAQ:INCY)

NTRA : 148.04 (+3.32%)
EXAS : 44.45 (+1.62%)
INCY : 56.87 (+3.08%)
REGN : 554.18 (+1.43%)
3 Growth Stocks That Have Turned $1,000 Into More Than $100,000 in 20 Years

Three stocks which have generated 100-bagger returns for investors over the past 20 years are Booking Holdings (NASDAQ: BKNG), Apple (NASDAQ: AAPL) , and Regeneron Pharmaceuticals (NASDAQ: REGN) . Here's...

AAPL : 198.15 (+4.06%)
REGN : 554.18 (+1.43%)
BKNG : 4,586.53 (+2.04%)
Roche's Higher Dose of Ocrevus Fails to Meet Goal in RMS Study

Swiss pharma giant Roche RHHBY faced a setback in its efforts to develop a higher dose of multiple sclerosis drug Ocrevus (ocrelizumab).The company announced that a phase III study, MUSETTE, which compared...

BAYRY : 5.9000 (+4.80%)
GILD : 103.63 (+2.20%)
REGN : 554.18 (+1.43%)
RHHBY : 38.1000 (+3.36%)
Retail Traders Mostly Bullish On Biotech Stocks Amid Blow From RFK Jr. Purge On Health Agencies

The sector's recent slide follows Peter Marks' resignation last week as the Food and Drug Administration's top vaccine regulator following a clash with Kennedy.

TECH : 50.72 (+2.96%)
VRTX : 484.22 (+1.84%)
MRNA : 26.20 (+6.94%)
REGN : 554.18 (+1.43%)
XBI : 74.33 (+3.80%)
Stocks Finish Higher as Magnificent Seven Stocks Rally

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.38%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.03%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.82%. June E-mini S&P...

ALK : 45.76 (+2.81%)
GOOGL : 157.14 (+2.83%)
UAL : 65.60 (+4.54%)
AAPL : 198.15 (+4.06%)
PVH : 68.88 (-0.39%)
ADI : 179.16 (+0.45%)
JNJ : 151.73 (+2.04%)
MRK : 79.18 (+2.10%)
TXN : 147.60 (-5.75%)
$IUXX : 18,690.05 (+1.89%)
PFE : 21.91 (+1.48%)
ZNM25 : 109-315 (+0.23%)
Dupixent® (dupilumab) Approved as the First-ever Biologic Medicine in Japan for Patients with Chronic Obstructive Pulmonary Disease (COPD)

REGN : 554.18 (+1.43%)
SNY : 51.50 (+3.71%)
Why Pharma and Biotech Stocks Got Thrashed on Tuesday

As ever in the often quick-developing biotech and pharmaceutical sectors on Tuesday, companies posted a mix of positive and negative news. Investors clearly took the latter more to heart, as they traded...

MRK : 79.18 (+2.10%)
REGN : 554.18 (+1.43%)
AMGN : 285.98 (+1.62%)
AXSM : 98.06 (+2.52%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Regeneron is a biotechnology company focused on the discovery, development and commercialization of treatments targeting serious medical conditions. The company's portfolio boasts nine marketed drugs - Eylea, Dupixent, Praluent, Kevzara, Libtayo, Evkeeza, Inmazeb Arcalyst and Zaltrap. The company also...

See More

Key Turning Points

3rd Resistance Point 584.32
2nd Resistance Point 569.93
1st Resistance Point 562.05
Last Price 554.18
1st Support Level 539.78
2nd Support Level 525.39
3rd Support Level 517.51

See More

52-Week High 1,211.20
Fibonacci 61.8% 949.45
Fibonacci 50% 868.59
Fibonacci 38.2% 787.74
Last Price 554.18
52-Week Low 525.99

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar